Atlas Trials

Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma

Clinical trial NCT04965454 · RECRUITING

Trial details

NCT number
NCT04965454
Sponsor
Queen's Medical Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma Non-resectable
Start date
2022-03-28
Primary completion
2027-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.